Investor Relations

Press Releases

Date Title/Summary View
Toggle Summary Aastrom Biosciences Achieves Clinical Milestone in Its Phase I/II U.S. Bone Grafting Trial
-- Safety Endpoint for TRC Product Reached; Trial Expanded --
View HTML
Toggle Summary Aastrom Biosciences Announces Appointment of Janet M. Hock, B.D.S., Ph.D. As Vice President Global Research
Aastrom Biosciences Announces Appointment of Janet M. Hock, B.D.S., Ph.D. As Vice President Global Research Ann Arbor, Michigan, September 14, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced the appointment of Janet M. Hock, B.D.S., Ph.D. as Vice President Global Research. Dr.
View HTML
Toggle Summary Aastrom Biosciences Announces Management Succession Process
-- Long-Term CEO and Chairman to Continue at Board Level --
View HTML
Toggle Summary Aastrom Biosciences Awarded NIH Grant to Develop Immunotherapy for the Treatment of Malignant Melanoma
-- Aastrom's Proprietary Technology Used to Produce Therapeutic Quantities of T-Cells --
View HTML
Toggle Summary Aastrom Biosciences CEO to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference
Aastrom Biosciences CEO to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference Ann Arbor, Michigan, October 25, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today R. Douglas Armstrong, Ph.D., Chairman and Chief Executive Officer, will present at the Rodman &
View HTML
Toggle Summary Aastrom Biosciences CEO to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference
Aastrom Biosciences CEO to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference Ann Arbor, Michigan, November 3, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today R. Douglas Armstrong, Ph.D., Chairman and Chief Executive Officer, will present at the Rodman & Renshaw
View HTML
Toggle Summary Aastrom Biosciences Concludes October 2002 Common Stock Agreement with Fusion Capital
-- Final $12 Million Tranche Completed at Premium to Market --
View HTML
Toggle Summary Aastrom Biosciences Receives NIH Grant Extending Proprietary Adult Stem Cell Process to Other Tissues
-- Phase II Grant to Support Bone Formation and Vascularization Capabilities of Company's Tissue Repair Cells --
View HTML
Toggle Summary Aastrom Biosciences to Hold Investor Conference Call Tomorrow
Aastrom Biosciences to Hold Investor Conference Call Tomorrow Ann Arbor, Michigan, April 28, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it will hold an investor conference call tomorrow, Thursday, April 29, 2004 at 11:00 a.m. (EDT).
View HTML
Toggle Summary Herbert S. Schwartz, M.D. Appointed to Aastrom Biosciences' Technology Review Board
Herbert S. Schwartz, M.D. Appointed to Aastrom Biosciences' Technology Review Board Ann Arbor, Michigan, October 14, 2003 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced the appointment of Herbert S. Schwartz, M.D. to its Technology Review Board (TRB). Dr.
View HTML